ARS Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SPRY | AVIR | ARDX | ARMP | AUPH | APGE | |
|---|---|---|---|---|---|---|
| Market cap | 303.31M | 357.71M | 849.44M | 116.75M | 2.29B | — |
| P/E (TTM) | — | — | — | — | 7.5 | — |
| Forward P/E | -3.4 | -3.0 | 11.2 | -1.5 | 14.8 | — |
| Price/book | 24.2 | 1.8 | 4.8 | -0.5 | 3.5 | — |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −66.30% | +28.70% | −49.08% | −45.41% | +14.60% | — |
| Today | 0.00% | +6.95% | +8.58% | +1.62% | +3.32% | 0.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All SPRY news ›ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling
Seeking Alpha - ARS Pharmaceuticals is rated Buy, with current market pricing disconnected from fundamental pipeline value despite commercial setbacks. - neffy, the flagship intranasal epinephrine spray, faces slo
SS&C Wins New Chance at Arcesium in FinTech Trade Secrets Suit
Bloomberg Law News SS&C Technologies Holdings Inc. convinced the Second Circuit to revive its trade secrets claims against financial technology competitor Arcesium LLC that arose out of a 2020 antitrust suit. SS&C plausibly alleged that
South African tycoon Stephen Saad's Aspen sells menopause drug rights for $220 million
Aspen Pharmacare, led by South African tycoon Stephen Saad, is selling the European rights to its menopause treatment Ovestin to Ennogen for €197 million. Aspen Pharmacare Holdings Ltd., the drugmaker led by South African tycoon Stephen…
Investor alleges alkaline water startup hid sales data in white text
A Texas investor alleges an alkaline water startup hid sales data inside his royalty statements - in white text. A federal lawsuit filed October 29 in Wyoming alleges a small beverage and labeling technology company took at least $3…
Class Action Lawsuit Filed: Telix Pharmaceuticals Ltd. (TLX) - Join by January 9, 2026 - Contact Levi & Korsinsky
November 17, 2025 9:19 AM EST | Source: Levi & Korsinsky, LLP New York, New York--(Newsfile Corp. - November 17, 2025) - If you suffered a loss on your Telix Pharmaceuticals Ltd. (NASDAQ: TLX) investment and want to learn about a potential…
Pharma tycoon Stephen Saad's Aspen stake gains $142m in 2026
Aspen Pharmacare's founder holds shares worth $558.7 million after a 34% rally this year, yet the stake remains $1 billion below its 2015 peak. South African pharmaceutical tycoon Stephen Saad's stake in Aspen Pharmacare, Africa's largest…
ILLR Investors Have Opportunity to Lead Triller Group Inc. Securities Fraud Lawsuit
PR Newswire NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Triller Group Inc. (NASDAQ: ILLR)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
PR Newswire NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACA
Securities – Fraud – Vaccine
Balancing crisis communications and legal risk Securities – Fraud – Vaccine Mass. Lawyers Weekly Staff//October 14, 2026// Where a plaintiff has alleged that a corporation and its executives violated the Securities Exchange Act by…
AGs, FTC Move To Hold Martin Shkreli In Contempt
KFBK News Radio The Federal Trade Commission (FTC) and attorneys general from seven states are asking a federal judge to hold Martin Shkreli in civil contempt for allegedly violating a lifetime ban from the pharmaceutical industry.…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- pluang.com5
- prnewswire.com4
- accessnewswire.com2
- billionaires.africa2
- law360.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.